Paul Van Gompel

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Alain Schotte, Paul Janssen, W Gommeren et al. · Psychopharmacology · 1996 · 1.2K citations · Full text

Psychoactive Drug, Psychiatry, Psychotropic Medication +9

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

J.E. Leysen, W Gommeren, Paul Van Gompel et al. · Molecular Pharmacology · 1985 · 452 citations

Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone

J.E. Leysen, Paul Van Gompel, W Gommeren et al. · Psychopharmacology · 1986 · 153 citations

Neurophysiology, Medicine, Behavioral Pharmacology +11

Differences in Signal Transduction of Two 5-HT4Receptor Splice Variants: Compound Specificity and Dual Coupling with Gαs- and Gαi/o-Proteins

Armelle Pindon, Geert Van Hecke, Paul Van Gompel et al. · Molecular Pharmacology · 2002 · 112 citations

Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.

J.E. Leysen, W Gommeren, Lieve Heylen et al. · Molecular Pharmacology · 1996 · 91 citations